Table 3.
Main Characteristics of Patients with or without Significant Bleeding
| Clinical Characteristics | Significant Bleeding (n=47) | Nonsignificant Bleeding (n=102) | p-value |
|---|---|---|---|
| Age | 44 (3–74) | 40 (8–83) | 0.426 |
| Sex (n) | 0.487 | ||
| Male | 22 | 54 | |
| Female | 25 | 48 | |
| WBC (×109/L) | 10.00 (0.49–258.01) | 3.11 (0.37–78.19) | 0.013 |
| Circulating leukemic cell percentage (%) | 77 (0–98.5) | 41 (0–97.5) | 0.002 |
| Absolute number of circulating leukemic cells (×109/L) | 6.78 (0 −250.27) | 1.20 (0 −59.21) | 0.005 |
| BMP (%) | 86.8 (13–95.4) | 81.1 (29.5–94.4) | 0.003 |
| PLT (×109/L) | 22 (1–84) | 27 (4–319) | 0.117 |
| PT (s) | 17 (11–27.4) | 13.55 (9.8–25.4) | <0.001 |
| APTT (s) | 28.5 (19.3–49.4) | 28.9 (15.3–54.1) | 0.967 |
| FIB (g/L) | 1.02 (0.31–3.33) | 1.35 (0.19–6.01) | 0.009 |
| D-Dimer (mg/L) | 20.00 (4.17–81.2) | 10.93 (0.71–152.53) | <0.001 |
| LDH (U/L) | 381 (136–2810) | 278 (113–7836) | 0.03 |
| CREA (µmol/L) | 54 (25–181) | 58 (22–154) | 0.202 |